Publications
5530 Results
- Journal / Conference
- ASCO :#C959
- Year
- 1987
- Research Committee(s)
- Genitourinary
Phase II clinical trial of IL-2/LAK in metastatic renal cancer.
- Journal / Conference
- ASCO 6:246(#970)
- Year
- 1987
- Research Committee(s)
- Melanoma
Phase II study of high dose interleukin-2 (IL-2) and lymphokineactivated killer (LAK) cells in patients (pts) with melanoma.
- Journal / Conference
- ASCO :#C-549
- Year
- 1987
Phase II trial of continuous infusion cytarabine (ARA-C) and bolus cis-platin (CDDP) in advanced solid tumors: renal, gastric, esophageal, pancreatic, and unknown primary cancers.
- Journal / Conference
- ASCO :#C-922
- Year
- 1987
Hepatitis a (HAV) infection occurring following IL-2/LAK cell therapy.
- Journal / Conference
- ASCO :#C-988
- Year
- 1987
Toxicity (TOX) of interleukin-2 and lymphokine-activated killer (LAK) cell therapy.
- Journal / Conference
- ASCO :#C-906
- Year
- 1987
Quality Control (QC) of the Community Clinical Oncology Program (CCOP) institutions within the Southwest Oncology Group (SWOG).
- Journal / Conference
- ASCO :#C-894
- Year
- 1987
Response assessment errors for all Southwest Oncology Group (SWOG) clinical trials are more likely overestimates of response.
- Journal / Conference
- Proc of the Fourth Intl Symp on Therapy of Acute Leukemias-Rome :250(233)
- Year
- 1987
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8694 (CALGB-8582) (NSC-377523) (NSC-218321)
Current Cancer and Leukemia Group B (CALGB) trials in the treatment of active hairy cell leukemia (HCL): A status report.
- Journal / Conference
- JCO 4(3):296-305
- Year
- 1986
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7426/7427, SWOG-7713/14
Effect of age on therapeutic outcome in advanced diffusehistiocytic lymphoma: the Southwest Oncology Group experience.
- Journal / Conference
- Blood 68(4):837-845
- Year
- 1986
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-7426/7427, SWOG-7713/14